Stoke Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Stoke Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Stoke Therapeutics Inc
Rating: 2.165680625
Author: Trendlyne DVM scores

Turnaround Potential

about

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antis...

33.96 0.77 (2.32%)

New 52W High in past week

555.6K

XNAS Volume

XNAS 16 Mar, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Stoke Therapeutics Inc is on 18 Mar 2026 for the purpose of Stoke Therapeutics Inc Fourth Quarter Earnings Results for 2025 See details

Medium Financial Strength

38.9 / 100

Mid Valuation

32.2 / 100

Technically Moderately Bullish

63.3 / 100

Turnaround Potential These stocks have average financials and valuation, but strong momentum indicating buying interest View Similar Embed DVM

1Yr Price target upside is 23%

10 analysts

Stoke Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Stoke Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antis...

New 52W High in past week

SWOT Analysis

Stoke Therapeutics Inc Live Price Chart